Skip to main content
SpringerLink
Log in

Gene therapy for multiple sclerosis

  • Chapter
Gene Therapy in Inflammatory Diseases

Part of the book series: Progress in Inflammation Research ((PIR))

  • 140 Accesses

Abstract

Recent advances in the field of immunology have increased our understanding of the pathology and regulation of autoimmune diseases. This knowledge is allowing the scientific community to consider the treatment of these diseases using new modalities of immunotherapy. The classic forms of therapy for autoimmune disease are directed at general suppression of the immune response. In contrast, newer forms of therapy are aimed at specific cells or cytokines that contribute to or regulate the aberrant immune response.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. IFNB MS Study Group (1995) Interferon beta-lβ in the treatment of multiple sclerosis: Final outcome of the randomized controlled trial. Neurology 45: 1277–1285

    Article  Google Scholar 

  2. Inobe JI, Chen Y, Weiner H (1996) In vivo administration of IL-4 induces TGF-beta-producing cells and protects animals from experimental autoimmune encephalomyelitis. Annul NY Acad Sci 778:390–392

    Article  CAS  Google Scholar 

  3. Johns, LD, Flanders KC, Ranges GE, Sriram S (1991) Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-beta 1. J.Immunol 147: 1792–1796

    PubMed  CAS  Google Scholar 

  4. Racke MK, Dhib-Jalbut S, Cannella B, Albert PS, Raine CS, McFarlin D (1991) Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1. J. Immunol 146: 3012–3017

    PubMed  CAS  Google Scholar 

  5. Steinman L(1996) A few autoreactive cells in an autoimmune infiltrate control a vast population of nonspecific cells: a tale of smart bombs and the infantry. Proc Natl Acad Sci USA 93:2253–2256

    Google Scholar 

  6. Shaw MK, Lorens JB, Dhawan A, DalCanto R, Tse HY, Tran AB, Bonpane C, Eswaran SL, Brocke S, Sarvetnick N, Steinman L, Nolan GP, Fathman CG (1997) Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis. J.Exp Med 185: 1711–1714

    Article  PubMed  CAS  Google Scholar 

  7. Mathisen PM, Yu M, Johnson JM, Drazba JA, Tuohy VK (1997) Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells. J.Exp Med 186: 159–164

    Article  PubMed  CAS  Google Scholar 

  8. Blaese RM, Culver KW, Miller AD, Carter CS, Fleisher T, Clerici M, Shearer G, Chang L, Chiang Y, Tolstoshev P et al (1995) T lymphocyte-directed gene therapy for ADA-SOD: initial trial results after 4 years. Science 270: 475–480

    Article  PubMed  CAS  Google Scholar 

  9. Dranoff G (1997) Strategies for cancer gene therapy. Cancer Chemother Biol Response Modif 17: 328–348

    PubMed  CAS  Google Scholar 

  10. Xu L, Sanchez A, Yang Z, Zaki SR, Nabel EG, Nichol ST, Nabel GJ (1998) Immunization for Ebola virus infection. Nature Med 4: 37–42

    Article  PubMed  CAS  Google Scholar 

  11. Schmidt-Wolf G, Schmidt-Wolf IGH (1995) Cytokines and gene therapy. Immunol Today 25: 1137–1140

    CAS  Google Scholar 

  12. Kren BT, Bandyopadhyay P, Steer CJ (1998) In vivo site-directed mutagenesis of the factor IX gene by chimeric RNA/DNA oligonucleotides. Nature Med 4(3): 285–290

    Article  PubMed  CAS  Google Scholar 

  13. Cosset FL, Morling FJ, Takeuchi Y, Weiss RA, Collins MK, Russell SJ (1996) Retroviral retargeting by envelopes expressing an N-terminal binding domain. J.Virol 69(10): 6314–6322

    Google Scholar 

  14. Hofmann A, Nolan GP, Blau HM (1996) Rapid retroviral delivery of tetracycline-inducible genes in a single autoregulatory cassette. Proc Natl Acad Sci USA 93: 5185–5190

    Article  PubMed  CAS  Google Scholar 

  15. Yang N-S, Sin WH (1995) Gene gun and other non-viral approaches for cancer gene therapy. Nature Med 1: 481–483

    Article  PubMed  CAS  Google Scholar 

  16. Croxford JL, Triantaphyllopoulos K, Podhajcer OL, Feldmann M, Baker D, Cherna-jovsky Y (1998) Cytokine gene therapy in experimental allergic encephalomyelitis by injection of plasmid DNA-cationic liposome complex into the central nervous system. J. Immunol 160: 5181–5187

    PubMed  CAS  Google Scholar 

  17. Pear WS, Nolan GP, Scott ML, Baltimore D (1993) Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci USA 90: 8392–8396

    Article  PubMed  CAS  Google Scholar 

  18. Gunzburg WH, Fleuchaus A, Sailer R, Salmons B (1996) Retroviral vector targeting for gene therapy. Cytokines Mol Ther 2:177–184

    PubMed  CAS  Google Scholar 

  19. Kuby J (1997) The immune system in AIDS. In: Immunology. W.H. Freeman and Company, New York, 523–553

    Google Scholar 

  20. Bansil S, Cook SD, Rohowsky-Kochan C (1995) Multiple sclerosis: immune mechanism and update on current therapies. Ann Neurol 37(1): S87–S101

    Article  PubMed  Google Scholar 

  21. Kurtzke JF (1977) Geography in multiple sclerosis. J.Neurol 215(1): 1–26

    Article  PubMed  CAS  Google Scholar 

  22. Voskuhl RR, Goldstein AM, Simonis T, Davey RJ, McFarland HF (1996) DR2/DQwl inheritance and haplotype sharing in affected siblings from multiple sclerosis families. Ann Neurol 39: 804–807

    Article  PubMed  CAS  Google Scholar 

  23. Ebers GC, Bulman DE, Sadovnick AD, Paty DW, Warren S, Hader W, Murray TJ, Seland TP, Duquette P, Grey T et al (1986) A population-based study of multiple sclerosis in twins. N Engl J Med 315: 1638–1642

    Article  PubMed  CAS  Google Scholar 

  24. Soldan SS, Berti R, Salem N, Secchiero P, Flamand L, Calabresi PA, Brennan MB, Maloni HW, McFarland HF, Lin HC, Patnaik M, Jacobson S (1997) Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nature Med 3: 1394–1397

    Article  PubMed  CAS  Google Scholar 

  25. Dalgleish AG (1997) Viruses and multiple sclerosis. Acta Neurol Scand Suppl 169: 8–15

    Article  PubMed  CAS  Google Scholar 

  26. Swanborg RH (1995) Experimental autoimmune encephalomyelitis in rodents as a model for human demyelinating disease. Clin Immunol Immunopathol 77:4–13

    Article  PubMed  CAS  Google Scholar 

  27. Kies MW (1965) Chemical studies on an encephalitogenic protein from guinea pig brain. Ann NY Acad Sci 122:161–168

    Article  CAS  Google Scholar 

  28. Yamamura T, Namikawa T, Endoh M, Kunishita T, Tabira T (1986) Experimental allergic encephalomyelitis induced by proteolipid apoprotein in Lewis rats. J.Neuroimmunol 12: 143–153

    Article  PubMed  CAS  Google Scholar 

  29. Burns J, Rosenzweig A, Zweiman B, Moskovitz A, Lisak R (1984) Recovery of myelin basic protein reactive T cells from spinal cords of Lewis rats with autoimmune encephalomyelitis. J.Immunol 132: 2690–2692

    PubMed  CAS  Google Scholar 

  30. Brostoff SW, Mason DW (1984) Experimental allergic encephalomyelitis: successful treatment in vivo with a monoclonal antibody that recognizes T helper cells. J.Immunol 133: 1938–1942

    PubMed  CAS  Google Scholar 

  31. Ben-Nun A, Lando Z (1983) Detection of autoimmune cells proliferating to myelin basic protein and selection of T cell lines that mediate experimental autoimmune encephalomyelitis (EAE) in mice. J.Immunol 130: 1205–1209

    PubMed  CAS  Google Scholar 

  32. Zamvil SS, Nelson PA, Mitchell DJ, Knobler RL, Fritz RB, Steinman L (1985) Encephalitogenic T cell clones specific for myelin basic protein. An unusual bias in antigen recognition. J.Exp Med 162: 2107–2124

    Article  PubMed  CAS  Google Scholar 

  33. Kalman B, Alder H, Lublin FD (1995) Characteristics of the T lymphocytes involved in experimental allergic encephalomyelitis. J.itNeuroimmunol 61: 107–116

    Article  CAS  Google Scholar 

  34. Issazadeh S, Ljungdahl A, Hojeberg B, Mustafa M, Olsson T (1995) Cytokine production in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis: dynamics of mRNA expression for interleukin-10, interleukin-12, cytolysin, tumor necrosis factor alpha and tumor necrosis factor beta. J.Neuroimmunol 61: 205–212

    Article  PubMed  CAS  Google Scholar 

  35. Olsson T (1995) Cytokine-producing cells in experimental autoimmune encephalomyelitis and multiple sclerosis. Neurology 45(6): S11–S15

    Article  PubMed  CAS  Google Scholar 

  36. Saoudi A, Simmonds S, Huitinga I, Mason D (1995) Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigen to B cells: evidence that the protective mechanism depends on changes in the cytokine response and migratory properties of the autoantigen-specific T cells. J.Exp Med 182:335–344

    Article  PubMed  CAS  Google Scholar 

  37. Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL (1994) Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265: 1237–1240

    Article  PubMed  CAS  Google Scholar 

  38. Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, Weiner HL, Nabavi N, Glimcher LH (1995) B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80: 707–718

    Article  PubMed  CAS  Google Scholar 

  39. Karpus WJ, Gould KE, Swanborg RH (1992) CD4+ suppressor cells of autoimmune encephalomyelitis respond to T cell receptor-associated determinants on effector cells by interleukin-4 secretion. Eur J Immunol 22: 1757–1763

    Article  PubMed  CAS  Google Scholar 

  40. Gaur A, Boehme SA, Chalmers D, Crowe PD, Pahuja A, Ling N, Brocke S, Steinman L, Conlon PJ (1997) Amelioration of relapsing experimental autoimmune encephalomyelitis with altered myelin basic protein peptides involves different cellular mechanisms. J Neuroimmunol 74: 149–158

    Article  PubMed  CAS  Google Scholar 

  41. Jamieson BD, Ahmed R (1989) T cell memory. Long-term persistence of virus-specific cytotoxic T cells. J Exp Med 169: 1993–2005

    Article  PubMed  CAS  Google Scholar 

  42. Cross AH, Cannella B, Brosnan CF, Raine C (1990) Homing to central nervous system vasculature by antigen-specific lymphocytes. I. Localization of 14C-labeled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis. Lab Invest 63: 162–170

    PubMed  CAS  Google Scholar 

  43. Skundric DS, Kim C, Tse HY, Raine CS (1993) Homing of T cells to the central nervous system throughout the course of relapsing experimental autoimmune encephalomyelitis in Thy-1 congenic mice. J Neuroimmunol 46: 113–121

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Wayne State University School of Medicine, 540 E. Canfield, Detroit, MI, 48201, USA

    Michael K. Shaw & Richard DalCanto

  2. Department of Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, 94305-5111, USA

    C. Garrison Fathman

Authors
  1. Michael K. Shaw
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Richard DalCanto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Garrison Fathman
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Center for Molecular Orthopaedics, Harvard Medical School, 221 Longwood Avenue, Room BL 152, Boston, MA, 02115, USA

    Christopher H. Evans

  2. University of Pittsburgh School of Medicine, W1246, Biological Sciences Tower, Pittsburgh, PA, 15261, USA

    Paul D. Robbins

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer Basel AG

About this chapter

Cite this chapter

Shaw, M.K., DalCanto, R., Garrison Fathman, C. (2000). Gene therapy for multiple sclerosis. In: Evans, C.H., Robbins, P.D. (eds) Gene Therapy in Inflammatory Diseases. Progress in Inflammation Research. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8478-5_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-0348-8478-5_8

  • Publisher Name: Birkhäuser, Basel

  • Print ISBN: 978-3-0348-9584-2

  • Online ISBN: 978-3-0348-8478-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation